Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and gdc-0068

capecitabine has been researched along with gdc-0068 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bozoghlanian, M; Cui, Y; Frankel, PH; Martinez, N; Murga, M; Patel, N; Ruel, C; Schmolze, D; Stewart, D; Tang, A; Tumyan, L; Vora, L; Waisman, J; Yost, SE; Yuan, Y1

Trials

1 trial(s) available for capecitabine and gdc-0068

ArticleYear
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
    The oncologist, 2023, 07-05, Volume: 28, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Humans; Paclitaxel; Triple Negative Breast Neoplasms

2023